Page last updated: 2024-09-03

valdecoxib and Liver Dysfunction

valdecoxib has been researched along with Liver Dysfunction in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alsalameh, S; Burian, M; Geisslinger, G; Mahr, G; Woodcock, BG1
Britto, MR; Mainka, MB; Parivar, K; Sarapa, N1

Reviews

1 review(s) available for valdecoxib and Liver Dysfunction

ArticleYear
Review article: The pharmacological properties and clinical use of valdecoxib, a new cyclo-oxygenase-2-selective inhibitor.
    Alimentary pharmacology & therapeutics, 2003, Feb-15, Volume: 17, Issue:4

    Topics: Adult; Aged; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Biological Availability; Bone Diseases; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Drug Interactions; Dysmenorrhea; Female; Humans; Isoenzymes; Isoxazoles; Liver Diseases; Male; Membrane Proteins; Middle Aged; Mouth Diseases; Osteoarthritis; Pain; Prostaglandin-Endoperoxide Synthases; Rats; Sulfonamides

2003

Trials

1 trial(s) available for valdecoxib and Liver Dysfunction

ArticleYear
The effect of mild and moderate hepatic impairment on the pharmacokinetics of valdecoxib, a selective COX-2 inhibitor.
    European journal of clinical pharmacology, 2005, Volume: 61, Issue:4

    Topics: Adult; Aged; Area Under Curve; Cyclooxygenase 2 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Female; Half-Life; Humans; Isoxazoles; Lidocaine; Liver Diseases; Male; Matched-Pair Analysis; Metabolic Clearance Rate; Middle Aged; Sulfonamides

2005